This paper is in the following e-collection/theme issue:

Non-randomized Protocols and Methods (ehealth) (568)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/41209, first published .
Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial

Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial

Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial

Authors of this article:

Emily Oulousian1, 2, 3 Author Orcid Image ;   Seok Hoon Chung1, 2, 3 Author Orcid Image ;   Elie Ganni1, 2, 3 Author Orcid Image ;   Amir Razaghizad1, 2, 3 Author Orcid Image ;   Guang Zhang2 Author Orcid Image ;   Robert Avram4, 5 Author Orcid Image ;   Abhinav Sharma1, 2, 3 Author Orcid Image
Article Authors Cited by (2) Tweetations (5) Metrics

Journals

  1. Sharma A, MARQUES P, ZHANG G, OULOUSIAN E, CHUNG S, GANNI E, LOPES R, RAZAGHIZAD A, AVRAM R. Voice-assisted Artificial Intelligence-enabled Screening for Severe Acute Respiratory Syndrome Coronavirus 2 Exposure in Cardiovascular Clinics: Primary Results of the VOICE-COVID-19-II Randomized Trial. Journal of Cardiac Failure 2023;29(10):1456 View
  2. Marques P, Emami A, Zhang G, Lopes R, Razaghizad A, Avram R, Sharma A. Impact of age and comorbid heart failure on the utility of smart voice-assistant devices. European Heart Journal - Digital Health 2024;5(3):389 View